Clinical implications for vascular endothelial growth factor in the lung: friend or foe? - Wikidata - awgldk - TriplyDB

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

http://www.wikidata.org/entity/Q36625050

about

Cytogenomics of hexavalent chromium (Cr 6+) exposed cells: a comprehensive review Endocan and the respiratory system: a review Chromium genotoxicity: A double-edged sword Metal rich particulate matter impairs acetylcholine-mediated vasorelaxation of microvessels in mice Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.VEGF promotes malaria-associated acute lung injury in mice Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization Dexamethasone attenuates VEGF expression and inflammation but not barrier dysfunction in a murine model of ventilator-induced lung injury.Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung.Vascular endothelial growth factor genotypes and haplotypes contribute to the susceptibility of obstructive sleep apnea syndrome.Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A Role of HIF1A, VEGFA and VEGFR2 SNPs in the Susceptibility and Progression of COPD in a Spanish Population.Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol alleviates elastase-induced emphysema in a mouse model VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction Subchronic inhalation of soluble manganese induces expression of hypoxia-associated angiogenic genes in adult mouse lungs Pulmonary hypertension associated with COPD.Future perspectives for the treatment of pulmonary arterial hypertension.Gestational exposure of mice to secondhand cigarette smoke causes bronchopulmonary dysplasia blocked by the nicotinic receptor antagonist mecamylamine Tissue regeneration as next-generation therapy for COPD--potential applications Pathogenesis of emphysema: from the bench to the bedside.Prevention of elastase-induced emphysema in placenta growth factor knock-out mice.Pulmonary hypertension: advances in pathogenesis and treatment.Therapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine.What's new in asthma pathophysiology and immunopathology?Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia.Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?Physiological and pathological angiogenesis in the adult pulmonary circulation.Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases.Particulate matter-mediated release of long pentraxin 3 (PTX3) and vascular endothelial growth factor (VEGF) in vitro: Limited importance of endotoxin and organic content.Lung remodeling associated with recovery from acute lung injury.Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma.Serum angiopoietin-2 and CRP levels during COPD exacerbations.L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension.Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).Vascular Endothelial Growth Factor in Idiopathic Pulmonary Fibrosis. An Imbalancing Act.Angiogenesis in bronchial asthma.Cardiotoxicity with vascular endothelial growth factor inhibitor therapy

P2860

Q26991939-BF0669B4-C305-4E46-98FB-E4CBC7436552 Q28069363-91102742-5577-45A8-98DA-59C40D00A762 Q28383439-8DBFE116-C0DC-470E-A5DC-047ABFFCE760 Q28395650-EB3B3541-FE55-4F66-9392-7C59DA5807D2 Q33442068-3AAA8646-2144-4018-B129-539804CB687C Q33587506-EAA84050-EB64-4708-B484-41B40B13F4E2 Q34012249-6139B776-4F9F-4546-8BD5-948962CBC499 Q34603440-3415A7D6-C5F1-4081-A92E-31ECB1711F0C Q34607913-B764431F-0974-46C1-99BC-EA313620231F Q34775945-B1FE5B10-152A-48B4-B2DB-111FBDFEDAE7 Q35933136-37715386-91E7-465A-9164-DD9E66265666 Q36013304-3EF95093-5A56-4C37-90CF-40BF888BFE60 Q36127872-94203301-ECC7-43AB-89E2-F9C2337D2475 Q36450466-FCADC74B-4F3A-462E-B890-FEEEA8DE1FD3 Q36782431-1A6FC8A0-FFE6-4BBA-8D7F-8F502990FC15 Q36859451-A839A53D-4BB9-47BC-B2E0-B9EC126C116C Q36943648-81E165C0-0C33-41F0-81B6-56F66D90672B Q37072637-056B610B-C8CC-4BB9-AA65-C9BCF0330E95 Q37115944-416B4B3D-F449-4D8A-AB49-A83F1D7823F3 Q37153275-291E2EBF-F080-4707-BCEA-30BB62E6EC9A Q37463105-DDF2099E-A45E-46EB-827B-B2A7D09F2160 Q37744182-EDFF49FB-07A3-454E-95D3-D6736824E5BA Q37754900-4365086E-2B7F-4E2C-A8A0-EA948DEAE380 Q37798030-A1986E06-1CE5-4F19-BBD7-478314B2F6A7 Q37850374-D3AB453A-7104-40FF-A007-59D4C532F2B5 Q38109057-2E961692-6192-41AB-8A58-E82CEFBBB5BC Q38111715-0065B708-FD30-460A-98BE-DCA1D4863802 Q38382112-D3703855-B432-44CB-9C80-F4616FA34C1D Q38722121-D24538C1-53EC-4E14-846A-DC4EF62C3627 Q38994633-F61A2F0C-E839-4BDA-A4B2-B988DA784269 Q42511846-A2C30091-824C-444F-9DB8-912E44506DD0 Q45908560-D37DBE26-FD21-4A2B-9D9A-D5486343E031 Q46061181-A45C5A8B-DA9D-45C3-B345-814677B8B251 Q47117383-FE2E0AD2-0678-4493-B77F-45BDACE00884 Q47951147-3F3D0785-F82A-41AC-B094-21600B790700 Q53544254-F1D253F9-3264-427F-A8EC-0E90DB37E564 Q56991273-C203608A-28F7-4788-BD43-FCC46DFCE13E

P2860

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

http://www.wikidata.org/entity/Q36625050

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

@ast

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

@en

type

label

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

@ast

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

@en

prefLabel

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

@ast

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

@en

P1433

Q36625050-B375DF97-393C-41DF-BD49-D6FB1A606EC7

P1476

Q36625050-CD962519-537B-4EB8-B97D-50CAD15CE482

P2093

Q36625050-50F94353-F403-4E2F-AAA9-46E768F7077D

Q36625050-A4A26261-7797-4B7E-9484-BB61FA630876

Q36625050-B7D5A060-0A3B-4A4E-BE59-7BAB2664F174

Q36625050-E18ECC80-C6C2-4E95-A65A-A05E7319B8A6

P275

Q36625050-C8137B92-B891-464F-9E7D-16C3B2118306

P2860

Q36625050-00F36642-76DE-4AF7-87F9-3B764196D2C2

Q36625050-0592ECCB-72C2-4D34-9529-863C9A76BC31

Q36625050-0A65A21F-A6F6-4229-A3AC-56BB0023B1AE

Q36625050-0B733132-B7C0-467A-B9FA-A690523CD007

Q36625050-1279E72E-A20F-4BB5-8303-ECB219E56D71

Q36625050-1BDF2932-263F-453D-A209-B7A081864637

Q36625050-1CDE1845-C0C9-4E6A-BB4C-902EA3F5A7F5

Q36625050-201FAABE-A5B7-477C-AC3B-B64104B4F47A

Q36625050-2B28FE5F-7C9F-4308-A966-DEC1AB17C6CB

Q36625050-2C2A8662-1BF0-4D4D-ACC7-89FE6CF9CF4A

P2888

Q36625050-B0B44D7B-77CB-4349-B6BD-6C3A56A4AA9A

P304

Q36625050-6A6BEE0F-8165-4BB7-A381-ADD607A136D2

P31

Q36625050-3729B4C6-446D-471F-B390-3EDA3DAA6377

Q36625050-9A7DA57D-C5BA-4BFA-968B-9263DDBFA95B

P356

Q36625050-160F3698-C774-4126-AF5F-7FC1E2920EDF

P478

Q36625050-4CF7B9C3-4908-4ECB-88C5-AA3F4012A488

P577

Q36625050-DFA51F64-4D66-4AD1-8B8F-B95750B1082B

P5875

Q36625050-FC54A6CA-C07D-4E3E-9CA0-C40A10543422

P6179

Q36625050-20EF8BDF-CD7B-41B4-A35A-9A048428DA86

P698

Q36625050-D453CD70-C787-4592-B42B-874545B1A96C

P921

Q36625050-23147A94-D4CB-4863-B1BA-8D0DBC87E66A

Q36625050-76829D44-6168-4328-BB50-9A287C12C317

Q36625050-7BD3B24A-1E32-401B-9E93-81D920B4C300

Q36625050-A2E7F118-860C-4541-ADE5-B03605482790

Q36625050-B7EC5401-9164-495F-9742-36CEBA7B30C4

P932

Q36625050-96BB99CC-F753-4DC4-A1B1-BC3FD82C2FFF

P356

1465-9921-7-128

P1433

Respiratory Research

P1476

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

@en

P2093

Andriana I Papaioannou

http://www.w3.org/2001/XMLSchema#string

Konstantinos I Gourgoulianis

http://www.w3.org/2001/XMLSchema#string

Konstantinos Kostikas

http://www.w3.org/2001/XMLSchema#string

Panagoula Kollia

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.

The biology of VEGF and its receptors

Vascular endothelial growth factor in pleural effusions of different origin

Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice

Vascular-specific growth factors and blood vessel formation

Vascular endothelial growth factor (VEGF) and its receptors

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.

Molecular and biological properties of vascular endothelial growth factor.

VEGF: an update on biological and therapeutic aspects.

Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension.

P2888

1465-9921-7-128

P304

128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-7-128

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6750556

http://www.w3.org/2001/XMLSchema#string

P6179

1008034986

http://www.w3.org/2001/XMLSchema#string

P698

17044926

http://www.w3.org/2001/XMLSchema#string

P921

regulation of gene expression

Anagraw amesgunef

P932

1629021

http://www.w3.org/2001/XMLSchema#string